Here are Pauli’s previews as Raisio reports its Q3 results on Tuesday, November 10 
We expect revenue to have grown moderately, driven by Elovena, but earnings to have slightly weakened compared to the strong comparison period, burdened among other things by ERP costs. A key area of interest in the report is whether the company can maintain its earnings guidance, which we believe carries the risk of a profit warning. In addition, we are closely monitoring the progress of the Benecol brand renewal, as well as the new CEO’s potential first comments on strategic progress and priorities.